Cargando…
Improvement of the Rett Syndrome Phenotype in a Mecp2 Mouse Model Upon Treatment with Levodopa and a Dopa-Decarboxylase Inhibitor
Rett Syndrome is a neurodevelopmental autism spectrum disorder caused by mutations in the gene coding for methyl CpG-binding protein (MeCP2). The disease is characterized by abnormal motor, respiratory, cognitive impairment, and autistic-like behaviors. No effective treatment of the disorder is avai...
Autores principales: | Szczesna, Karolina, de la Caridad, Olga, Petazzi, Paolo, Soler, Marta, Roa, Laura, Saez, Mauricio A, Fourcade, Stéphane, Pujol, Aurora, Artuch-Iriberri, Rafael, Molero-Luis, Marta, Vidal, August, Huertas, Dori, Esteller, Manel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4200495/ https://www.ncbi.nlm.nih.gov/pubmed/24917201 http://dx.doi.org/10.1038/npp.2014.136 |
Ejemplares similares
-
Dysregulation of the long non-coding RNA transcriptome in a Rett syndrome mouse model
por: Petazzi, Paolo, et al.
Publicado: (2013) -
Circadian Cycle-Dependent MeCP2 and Brain Chromatin Changes
por: Martínez de Paz, Alexia, et al.
Publicado: (2015) -
Mecp2-Null Mice Provide New Neuronal Targets for Rett Syndrome
por: Urdinguio, Rocio G., et al.
Publicado: (2008) -
Mutations in JMJD1C are involved in Rett syndrome and intellectual disability
por: Sáez, Mauricio A., et al.
Publicado: (2016) -
Polymorphism of the Dopa-Decarboxylase Gene Modifies the Motor Response to Levodopa in Chinese Patients With Parkinson's Disease
por: Li, Lanting, et al.
Publicado: (2020)